Impax Laboratories, Inc. (NASDAQ: IPXL) announced that EMVERM (mebendazole) 100 mg chewable tablets are now available for healthcare providers to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE